Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Status:
Terminated
Trial end date:
2018-01-16
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the impact on quality of life of Lanreotide
Autogel 120 mg in combination with standard care, in comparison to the standard care alone,
in subjects affected by inoperable malignant bowel obstruction.